Liquidation: BIO-PATH HOLDINGS, INC.

Form Type: 8-K

Filing Date: 2025-06-24

Corporate Action: Liquidation

Type: Update

Accession Number: 000155837025008814

Filing Summary: On June 20, 2025, Peter H. Nielsen resigned from all positions including President and CEO of Bio-Path Holdings, Inc., followed by resignations of Board members Heath Cleaver and Aline Sherwood on June 20 and June 21, respectively, both indicating no disagreements with the company. On June 22, 2025, Douglas P. Morris was appointed as Chairman of the Board. The company has implemented an operational pause to conserve capital, leading to the furlough of most employees and a halt in operations as it seeks financing. The board is evaluating actions due to limited capital resources, warning that without additional funding, the company may delay or reduce its drug development programs, relinquish rights to technologies, or ultimately face liquidation.